242 related articles for article (PubMed ID: 24932684)
1. MIF family members cooperatively inhibit p53 expression and activity.
Brock SE; Rendon BE; Xin D; Yaddanapudi K; Mitchell RA
PLoS One; 2014; 9(6):e99795. PubMed ID: 24932684
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.
Brock SE; Rendon BE; Yaddanapudi K; Mitchell RA
J Biol Chem; 2012 Nov; 287(45):37917-25. PubMed ID: 22988252
[TBL] [Abstract][Full Text] [Related]
3. Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
Coleman AM; Rendon BE; Zhao M; Qian MW; Bucala R; Xin D; Mitchell RA
J Immunol; 2008 Aug; 181(4):2330-7. PubMed ID: 18684922
[TBL] [Abstract][Full Text] [Related]
4. D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
Guo D; Guo J; Yao J; Jiang K; Hu J; Wang B; Liu H; Lin L; Sun W; Jiang X
Int J Cancer; 2016 Nov; 139(9):2056-67. PubMed ID: 27434219
[TBL] [Abstract][Full Text] [Related]
5. Combined Knockdown of D-dopachrome Tautomerase and Migration Inhibitory Factor Inhibits the Proliferation, Migration, and Invasion in Human Cervical Cancer.
Wang Q; Wei Y; Zhang J
Int J Gynecol Cancer; 2017 May; 27(4):634-642. PubMed ID: 28338494
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
Pasupuleti V; Du W; Gupta Y; Yeh IJ; Montano M; Magi-Galuzzi C; Welford SM
J Biol Chem; 2014 Feb; 289(6):3713-23. PubMed ID: 24356968
[TBL] [Abstract][Full Text] [Related]
7. D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.
Merk M; Mitchell RA; Endres S; Bucala R
Cytokine; 2012 Jul; 59(1):10-7. PubMed ID: 22507380
[TBL] [Abstract][Full Text] [Related]
8. The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.
Xin D; Rendon BE; Zhao M; Winner M; McGhee Coleman A; Mitchell RA
Mol Cancer Res; 2010 Dec; 8(12):1601-9. PubMed ID: 21071513
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
[TBL] [Abstract][Full Text] [Related]
10. Thieno[2,3-
Xiao Z; Osipyan A; Song S; Chen D; Schut RA; van Merkerk R; van der Wouden PE; Cool RH; Quax WJ; Melgert BN; Poelarends GJ; Dekker FJ
J Med Chem; 2022 Feb; 65(3):2059-2077. PubMed ID: 35041425
[TBL] [Abstract][Full Text] [Related]
11. The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).
Merk M; Zierow S; Leng L; Das R; Du X; Schulte W; Fan J; Lue H; Chen Y; Xiong H; Chagnon F; Bernhagen J; Lolis E; Mor G; Lesur O; Bucala R
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E577-85. PubMed ID: 21817065
[TBL] [Abstract][Full Text] [Related]
12. Stromal-dependent tumor promotion by MIF family members.
Mitchell RA; Yaddanapudi K
Cell Signal; 2014 Dec; 26(12):2969-78. PubMed ID: 25277536
[TBL] [Abstract][Full Text] [Related]
13. Impaired DNA damage checkpoint response in MIF-deficient mice.
Nemajerova A; Mena P; Fingerle-Rowson G; Moll UM; Petrenko O
EMBO J; 2007 Feb; 26(4):987-97. PubMed ID: 17290223
[TBL] [Abstract][Full Text] [Related]
14.
Liao CH; Yong CY; Lai GM; Chow JM; Cheng CF; Fang CL; Lin PC; Chang CL; Zheng YM; Chuang SE; Whang-Peng J; Yao CJ
Am J Chin Med; 2020; 48(6):1491-1509. PubMed ID: 32924531
[No Abstract] [Full Text] [Related]
15. Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.
Rajasekaran D; Zierow S; Syed M; Bucala R; Bhandari V; Lolis EJ
FASEB J; 2014 Nov; 28(11):4961-71. PubMed ID: 25016026
[TBL] [Abstract][Full Text] [Related]
16. A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation.
Fingerle-Rowson G; Kaleswarapu DR; Schlander C; Kabgani N; Brocks T; Reinart N; Busch R; Schütz A; Lue H; Du X; Liu A; Xiong H; Chen Y; Nemajerova A; Hallek M; Bernhagen J; Leng L; Bucala R
Mol Cell Biol; 2009 Apr; 29(7):1922-32. PubMed ID: 19188446
[TBL] [Abstract][Full Text] [Related]
17. MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms.
Ochi A; Chen D; Schulte W; Leng L; Moeckel N; Piecychna M; Averdunk L; Stoppe C; Bucala R; Moeckel G
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F767-F780. PubMed ID: 28539339
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
Koga K; Kenessey A; Ojamaa K
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H282-93. PubMed ID: 23144312
[TBL] [Abstract][Full Text] [Related]
19. Evolving complexity of MIF signaling.
Jankauskas SS; Wong DWL; Bucala R; Djudjaj S; Boor P
Cell Signal; 2019 May; 57():76-88. PubMed ID: 30682543
[TBL] [Abstract][Full Text] [Related]
20. A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.
Winner M; Meier J; Zierow S; Rendon BE; Crichlow GV; Riggs R; Bucala R; Leng L; Smith N; Lolis E; Trent JO; Mitchell RA
Cancer Res; 2008 Sep; 68(18):7253-7. PubMed ID: 18794110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
